Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JXHB2500082	Iberdomide胶囊	iberdomide	Capsule	Chemical Drugs(1)	Supplementary Application	2025-07-02	Celgene Corporation;Alcami Corp	view
JXHL2300062	Iberdomide胶囊	iberdomide	Capsule	Chemical Drugs(1)	Import Drug Application	2023-03-30	Celgene Corporation;BRISTOL-MYERS Squibb (CHINA) Co Ltd	view
JXHL2300061	Iberdomide胶囊	iberdomide	Capsule	Chemical Drugs(1)	Import Drug Application	2023-03-30	Celgene Corporation;BRISTOL-MYERS Squibb (CHINA) Co Ltd	view
JXHL2300065	Iberdomide胶囊	iberdomide	Capsule	Chemical Drugs(1)	Import Drug Application	2023-03-30	Celgene Corporation;BRISTOL-MYERS Squibb (CHINA) Co Ltd	view
JXHB2500086	Iberdomide胶囊	iberdomide	Capsule	Chemical Drugs(1)	Supplementary Application	2025-07-02	Celgene Corporation;Alcami Corp	view
JXHL2300063	Iberdomide胶囊	iberdomide	Capsule	Chemical Drugs(1)	Import Drug Application	2023-03-30	Celgene Corporation;BRISTOL-MYERS Squibb (CHINA) Co Ltd	view
JXHB2500083	Iberdomide胶囊	iberdomide	Capsule	Chemical Drugs(1)	Supplementary Application	2025-07-02	Celgene Corporation;Alcami Corp	view
JXHL2300064	Iberdomide胶囊	iberdomide	Capsule	Chemical Drugs(1)	Import Drug Application	2023-03-30	Celgene Corporation;BRISTOL-MYERS Squibb (CHINA) Co Ltd	view
JXHB2500084	Iberdomide胶囊	iberdomide	Capsule	Chemical Drugs(1)	Supplementary Application	2025-07-02	Celgene Corporation;Alcami Corp	view
JXHB2500085	Iberdomide胶囊	iberdomide	Capsule	Chemical Drugs(1)	Supplementary Application	2025-07-02	Celgene Corporation;Alcami Corp	view